Otitis externa
- Overview
- Theory
- Diagnosis
- Management
- Follow up
- Resources
Treatment algorithm
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups: see disclaimer
bacterial
antibacterial otic drops
In people who do not have other medical issues such as diabetes, HIV/AIDS, other immunocompromised states, or a history of radiotherapy, and who do not have signs of fungal infection or necrotising otitis externa, initial presumptive treatment is with topical antibacterial ear drops, plus analgesia.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com
Prior to the use of topical ear drops, the ear canal needs to be cleaned of any debris or wax by dry swabbing or microsuction.[18]Barry V, Bhamra N, Balai E, et al. Otitis externa. BMJ. 2021 Mar 31;372:n714. https://www.bmj.com/content/372/bmj.n714.long http://www.ncbi.nlm.nih.gov/pubmed/33789841?tool=bestpractice.com
Patients who have severe swelling of the ear canal may have difficulty in using ear drops. A wick should be inserted in the ear canal to allow for drug delivery.
Ototoxic ear drops (those that contain aminoglycosides and alcohol) should be avoided in patients with possible tympanic membrane perforations, including those with a tympanostomy tube.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com [12]Jackson EA, Geer K. Acute otitis externa: rapid evidence review. Am Fam Physician. 2023 Feb;107(2):145-51. http://www.ncbi.nlm.nih.gov/pubmed/36791445?tool=bestpractice.com
Ciprofloxacin/dexamethasone, ofloxacin, and ciprofloxacin can be used in patients with perforated tympanic membranes.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com [31]Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003 Apr;22(4):299-305;quiz 306-8. http://www.ncbi.nlm.nih.gov/pubmed/12690268?tool=bestpractice.com
Primary options
ciprofloxacin/dexamethasone otic: (0.3%/0.1%) children ≥6 months of age and adults: 4 drops into the affected ear(s) twice daily for 7-10 days
OR
ofloxacin otic: (0.3%) children ≥6 months of age: 5 drops into the affected ear(s) once daily for 7 days; adults: 10 drops into the affected ear(s) once daily for 7 days
OR
ciprofloxacin otic: (0.2% solution) children and adults: 0.5 mg (0.25 mL single-use container) into the affected ear(s) twice daily for 7 days; (6% suspension) children ≥6 months of age and adults: 12 mg (0.2 mL single-use container) into external ear canal of the affected ear(s) as a single dose
Secondary options
ciprofloxacin/hydrocortisone otic: (0.2%/1%) children ≥1 year of age and adults: 3 drops into the affected ear(s) twice daily for 7-10 days
OR
neomycin/polymyxin B/hydrocortisone otic: children: 3 drops into the affected ear(s) three to four times daily for 7-10 days; adults: 4 drops into the affected ear(s) three to times daily for 7-10 days
pain management
Additional treatment recommended for SOME patients in selected patient group
Analgesics increase patient satisfaction and allow faster return to normal activities.
Mild to moderate pain is usually controlled by paracetamol or a non-steroidal anti-inflammatory drug given alone or in combination with an opioid (e.g., paracetamol with codeine or paracetamol with oxycodone).[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com Analgesics should be started at the initial recommended dose and adjusted accordingly.
Codeine is contraindicated in children younger than 12 years, and it is not recommended in adolescents aged 12-18 years who are obese or have conditions such as obstructive sleep apnoea or severe lung disease as it may increase the risk of breathing problems.[61]US Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children aged 12 years and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[62]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON287006 [63]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144851.pdf
Primary options
paracetamol: children: 10-15 mg/kg orally/rectally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
paracetamol/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 15-60 mg orally orally every 4-6 hours
More paracetamol/codeineAdults: dose refers to codeine component. Maximum dose is based on paracetamol component of 4000 mg/day.
OR
oxycodone/paracetamol: adults: 5-10 mg orally (immediate-release) every 4-6 hours when required
More oxycodone/paracetamolAdults: dose refers to oxycodone component. Maximum dose is based on paracetamol component of 4000 mg/day.
topical and systemic antibacterial therapy
Patients with diabetes or those who are immunocompromised benefit from the addition of oral antibiotics.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com In addition, patients who failed to respond to 48-72 hours of topical treatment, despite a correct diagnosis of diffuse acute otitis externa (AOE) and good adherence with treatment, may also benefit from systemic antibiotics, particularly if any ear canal obstruction cannot be addressed.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com Culture and sensitivity may help to guide antibiotic therapy in patients refractory to initial treatment. Patients with concurrent middle ear disease, such as acute otitis media or a tympanic membrane perforation, may also require systemic antibiotics.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com
Both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have issued warnings about serious, disabling, and potentially irreversible adverse effects associated with systemic and inhaled fluoroquinolone antibiotics. These adverse effects include tendonitis, tendon rupture, arthralgia, neuropathies, and other musculoskeletal or nervous system effects.[43]European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products [46]US Food and Drug Administration. FDA drug safety communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics [47]US Food and Drug Administration. FDA drug safety communication: FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. July 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side The EMA now recommends that fluoroquinolone antibiotics be restricted for use in serious, life-threatening bacterial infections only.[43]European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products The FDA has also issued certain restrictions.[45]US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 2016 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics Despite this, a systemic fluoroquinolone is usually required in patients with non-necrotising otitis externa who have comorbidities (diabetes or immunocompromised state), as they are at higher risk for rapid escalation from mild to severe manifestations of AOE or for developing necrotising otitis externa.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com [12]Jackson EA, Geer K. Acute otitis externa: rapid evidence review. Am Fam Physician. 2023 Feb;107(2):145-51. http://www.ncbi.nlm.nih.gov/pubmed/36791445?tool=bestpractice.com [42]Hannley MT, Denneny JC 3rd, Holzer SS. Use of ototopical antibiotics in treating 3 common ear diseases. Otolaryngol Head Neck Surg. 2000 Jun;122(6):934-40. http://www.ncbi.nlm.nih.gov/pubmed/10828818?tool=bestpractice.com Advice should be sought from an infectious diseases specialist to guide selection of antibiotic and decide on whether a fluoroquinolone is warranted here. In these patients, cultures may be taken to assist in the proper choice of oral antibiotics. Oral amoxicillin/clavulanate or amoxicillin are other options to cover Staphylococcus aureus if Pseudomonas aeruginosa is unlikely, or while awaiting results, or if cultures are negative.
Prior to the use of topical ear drops, the ear canal needs to be cleaned of any debris or wax by dry swabbing or microsuction.[18]Barry V, Bhamra N, Balai E, et al. Otitis externa. BMJ. 2021 Mar 31;372:n714. https://www.bmj.com/content/372/bmj.n714.long http://www.ncbi.nlm.nih.gov/pubmed/33789841?tool=bestpractice.com However, irrigation should not be used to remove debris from these patients’ ear canals, as this may predispose the patients to necrotising otitis externa.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com
Patients who have severe swelling of the ear canal may have difficulty in using ear drops. A wick should be inserted in the ear canal to allow for drug delivery.
Topical ciprofloxacin/dexamethasone, ofloxacin, and ciprofloxacin can be used in patients with perforated tympanic membranes and so are preferred in this situation.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com [31]Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003 Apr;22(4):299-305;quiz 306-8. http://www.ncbi.nlm.nih.gov/pubmed/12690268?tool=bestpractice.com
Treatment course: a 10-day course is usually sufficient.
Primary options
ciprofloxacin: children: consult specialist for guidance on dose; adults: 500-750 mg orally twice daily
or
amoxicillin: children ≤3 months of age: 30 mg/kg/day orally given in 2 divided doses; children >3 months of age: 20-40 mg/kg/day orally given in 3 divided doses (maximum 500 mg/dose), or 25-45 mg/kg/day orally given in 2 divided doses (maximum 875 mg/dose); adults: 250-500 mg orally three times daily, or 500-875 mg orally twice daily
More amoxicillinHigher doses may be required in some patients; consult a specialist or local protocols for further guidance.
or
amoxicillin/clavulanate: children ≤3 months of age: 30 mg/kg/day orally given in 2 divided doses; children >3 months of age: 20-40 mg/kg/day orally given in 3 divided doses (maximum 500 mg/dose), or 25-45 mg/kg/day orally given in 2 divided doses (maximum 875 mg/dose); adults: 250-500 mg orally three times daily, or 500-875 mg orally twice daily
More amoxicillin/clavulanateDose refers to amoxicillin component. Higher doses may be required in some patients; consult a specialist or local protocols for further guidance.
-- AND --
ciprofloxacin/dexamethasone otic: (0.3%/0.1%) children ≥6 months of age and adults: 4 drops into the affected ear(s) twice daily
or
ofloxacin otic: (0.3%) children ≥6 months of age: 5 drops into the affected ear(s) once daily; adults: 10 drops into the affected ear(s) once daily
or
ciprofloxacin otic: (0.2% solution) children and adults: 0.5 mg (0.25 mL single-use container) into the affected ear(s) twice daily
pain management
Additional treatment recommended for SOME patients in selected patient group
Analgesics increase patient satisfaction and allow faster return to normal activities.
Mild to moderate pain is usually controlled by paracetamol or a non-steroidal anti-inflammatory drug given alone or in combination with an opioid (e.g., paracetamol with codeine or paracetamol with oxycodone).[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com Analgesics should be started at the initial recommended dose and adjusted accordingly.
Codeine is contraindicated in children younger than 12 years, and it is not recommended in adolescents aged 12-18 years who are obese or have conditions such as obstructive sleep apnoea or severe lung disease as it may increase the risk of breathing problems.[61]US Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children aged 12 years and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[62]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON287006 [63]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144851.pdf
Primary options
paracetamol: children: 10-15 mg/kg orally/rectally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
paracetamol/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 15-60 mg orally orally every 4-6 hours
More paracetamol/codeineAdults: dose refers to codeine component. Maximum dose is based on paracetamol component of 4000 mg/day.
OR
oxycodone/paracetamol: adults: 5-10 mg orally (immediate-release) every 4-6 hours when required
More oxycodone/paracetamolAdults: dose refers to oxycodone component. Maximum dose is based on paracetamol component of 4000 mg/day.
topical and systemic antibacterial therapy plus debridement
Necrotising otitis externa is a medical emergency.[7]Frost J, Samson AD. Standardised treatment protocol for necrotizing otitis externa: retrospective case series and systematic literature review. J Glob Antimicrob Resist. 2021 Sep;26:266-71. https://www.sciencedirect.com/science/article/pii/S2213716521001661?via%3Dihub http://www.ncbi.nlm.nih.gov/pubmed/34273591?tool=bestpractice.com All patients in this group should have debridement of granulation tissue.
There are no unified guidelines for the management of necrotising otitis externa. Some clinicians advocate starting intravenous antibiotics immediately, while others start a trial of oral ciprofloxacin in patients who are suspected to have necrotising otitis externa not complicated by cranial nerve involvement.[48]Hopkins ME, Bennett A, Henderson N, et al. A retrospective review and multi-specialty, evidence-based guideline for the management of necrotising otitis externa. J Laryngol Otol. 2020 Jun;134(6):487-92. http://www.ncbi.nlm.nih.gov/pubmed/32498757?tool=bestpractice.com Patients who do not respond to oral antibiotics within 24-48 hours should then be started on intravenous antibiotics. The author's usual practice is to try oral ciprofloxacin in early uncomplicated or suspected necrotising otitis externa and assess the patient's response in 24-48 hours.
Both the European Medicines Agency (EMA) and the US Food and Drug Administration (FDA) have issued warnings about serious, disabling, and potentially irreversible adverse effects associated with systemic and inhaled fluoroquinolone antibiotics. These adverse effects include tendonitis, tendon rupture, arthralgia, neuropathies, and other musculoskeletal or nervous system effects.[43]European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products [46]US Food and Drug Administration. FDA drug safety communication: FDA warns about increased risk of ruptures or tears in the aorta blood vessel with fluoroquinolone antibiotics in certain patients. December 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-increased-risk-ruptures-or-tears-aorta-blood-vessel-fluoroquinolone-antibiotics [47]US Food and Drug Administration. FDA drug safety communication: FDA reinforces safety information about serious low blood sugar levels and mental health side effects with fluoroquinolone antibiotics; requires label changes. July 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-reinforces-safety-information-about-serious-low-blood-sugar-levels-and-mental-health-side The EMA now recommends that fluoroquinolone antibiotics be restricted for use in serious, life-threatening bacterial infections only.[43]European Medicines Agency. Quinolone- and fluoroquinolone-containing medicinal products. March 2019 [internet publication]. https://www.ema.europa.eu/en/medicines/human/referrals/quinolone-fluoroquinolone-containing-medicinal-products The FDA has also issued certain restrictions.[45]US Food and Drug Administration. FDA drug safety communication: FDA updates warnings for oral and injectable fluoroquinolone antibiotics due to disabling side effects. July 2016 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-updates-warnings-oral-and-injectable-fluoroquinolone-antibiotics Despite this, a systemic fluoroquinolone is required in patients with necrotising otitis externa.
Oral fluoroquinolones are active against Pseudomonas aeruginosa, penetrate the bone well, have excellent oral bioavailability, and have a less significant side effect profile compared with alternatives.[49]Carfrae MJ, Kesser BW. Malignant otitis externa. Otolaryngol Clin North Am. 2008 Jun;41(3):537-49;viii-ix. http://www.ncbi.nlm.nih.gov/pubmed/18435997?tool=bestpractice.com
Oral ciprofloxacin has good coverage against Pseudomonas aeruginosa and is very commonly and successfully used in these patients. Patients can be given oral ciprofloxacin for 6-8 weeks.[50]Bernstein JM, Holland NJ, Porter GC, et al. Resistance of Pseudomonas to ciprofloxacin: implications for the treatment of malignant otitis externa. J Laryngol Otol. 2007 Feb;121(2):118-23. http://www.ncbi.nlm.nih.gov/pubmed/16995959?tool=bestpractice.com
Topical ciprofloxacin/dexamethasone, ofloxacin, or ciprofloxacin can be used in conjunction with systemic ciprofloxacin and are safe to use in patients with tympanic membrane perforation.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com [31]Dohar JE. Evolution of management approaches for otitis externa. Pediatr Infect Dis J. 2003 Apr;22(4):299-305;quiz 306-8. http://www.ncbi.nlm.nih.gov/pubmed/12690268?tool=bestpractice.com Ototoxic ear drops (those that contain aminoglycosides and alcohol) should be avoided in patients with possible tympanic membrane perforations.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com [12]Jackson EA, Geer K. Acute otitis externa: rapid evidence review. Am Fam Physician. 2023 Feb;107(2):145-51. http://www.ncbi.nlm.nih.gov/pubmed/36791445?tool=bestpractice.com
If patients fail to respond to oral ciprofloxacin within 24-48 hours, they should be started on intravenous antibiotics that have antipseudomonal activity until culture and sensitivity results are obtained.
Primary options
ciprofloxacin: children: consult specialist for guidance on dose; adults: 500-750 mg orally twice daily for 6-8 weeks
-- AND --
ciprofloxacin/dexamethasone otic: (0.3%/0.1%) children ≥6 months of age and adults: 4 drops into the affected ear(s) twice daily for 7-10 days
or
ofloxacin otic: (0.3%) children ≥6 months of age: 5 drops into the affected ear(s) once daily for 7 days; adults: 10 drops into the affected ear(s) once daily for 7 days
or
ciprofloxacin otic: (0.2% solution) children and adults: 0.5 mg (0.25 mL single-use container) into the affected ear(s) twice daily for 7 days; (6% suspension) children ≥6 months of age and adults: 12 mg (0.2 mL single-use container) into external ear canal of the affected ear(s) as a single dose
hyperbaric oxygen
Additional treatment recommended for SOME patients in selected patient group
Hyperbaric oxygenation can be used in patients with refractory or recurrent disease, or in patients with extensive skull base or intracranial involvement although, in one systematic review, no clear evidence was found in demonstrating its efficacy when compared to treatment with antibiotics and/or surgery.[51]Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):316-23. http://www.ncbi.nlm.nih.gov/pubmed/14502060?tool=bestpractice.com [53]Amaro CE, Espiney R, Radu L, et al. Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre. Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1881-7. http://www.ncbi.nlm.nih.gov/pubmed/31165255?tool=bestpractice.com [54]Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2013 May 31;(5):CD004617. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004617.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23728650?tool=bestpractice.com
pain management
Additional treatment recommended for SOME patients in selected patient group
Analgesics increase patient satisfaction and allow faster return to normal activities.
Mild to moderate pain is usually controlled by paracetamol or a non-steroidal anti-inflammatory drug given alone or in combination with an opioid (e.g., paracetamol with codeine or paracetamol with oxycodone).[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com Analgesics should be started at the initial recommended dose and adjusted accordingly.
Codeine is contraindicated in children younger than 12 years, and it is not recommended in adolescents aged 12-18 years who are obese or have conditions such as obstructive sleep apnoea or severe lung disease as it may increase the risk of breathing problems.[61]US Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children aged 12 years and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[62]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON287006 [63]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144851.pdf
Primary options
paracetamol: children: 10-15 mg/kg orally/rectally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
paracetamol/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 15-60 mg orally orally every 4-6 hours
More paracetamol/codeineAdults: dose refers to codeine component. Maximum dose is based on paracetamol component of 4000 mg/day.
OR
oxycodone/paracetamol: adults: 5-10 mg orally (immediate-release) every 4-6 hours when required
More oxycodone/paracetamolAdults: dose refers to oxycodone component. Maximum dose is based on paracetamol component of 4000 mg/day.
intravenous antibiotic therapy plus debridement
All patients in this group should have debridement of granulation tissue.
Resistance to ciprofloxacin has been reported, but multi-drug resistance is rare.[7]Frost J, Samson AD. Standardised treatment protocol for necrotizing otitis externa: retrospective case series and systematic literature review. J Glob Antimicrob Resist. 2021 Sep;26:266-71. https://www.sciencedirect.com/science/article/pii/S2213716521001661?via%3Dihub http://www.ncbi.nlm.nih.gov/pubmed/34273591?tool=bestpractice.com If patients fail to respond to oral ciprofloxacin within 24-48 hours, they should be started on intravenous antibiotics that have anti-pseudomonal activity until culture and sensitivity results are obtained. Empirical intravenous antibiotics should be started based on the recommendation of the local infectious disease specialist. There is no standard recommendation, and the literature reports use of a wide range of antibiotics both singularly and in combination, including third- and fourth-generation cephalosporins (ceftazidime, cefepime), semi-synthetic penicillins (ticarcillin, piperacillin), carbapenems (imipenem), aztreonam, and aminoglycosides (amikacin, tobramycin).[51]Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):316-23. http://www.ncbi.nlm.nih.gov/pubmed/14502060?tool=bestpractice.com [52]Franco-Vidal V, Blanchet H, Bebear C, et al. Necrotizing external otitis: a report of 46 cases. Otol Neurotol. 2007 Sep;28(6):771-3. http://www.ncbi.nlm.nih.gov/pubmed/17721365?tool=bestpractice.com One retrospective case series and systematic literature review concluded that ceftazidime monotherapy for 6-7 weeks was effective for treating necrotising otitis externa.[7]Frost J, Samson AD. Standardised treatment protocol for necrotizing otitis externa: retrospective case series and systematic literature review. J Glob Antimicrob Resist. 2021 Sep;26:266-71. https://www.sciencedirect.com/science/article/pii/S2213716521001661?via%3Dihub http://www.ncbi.nlm.nih.gov/pubmed/34273591?tool=bestpractice.com In the absence of specialist infectious disease advice, the author considers ceftazidime a reasonable first choice, with the others as alternative options. Suggested doses could vary depending on factors such as the patient's renal function and severity of infection. Amikacin and tobramycin have serious potential side effects on renal function and hearing and should be used with caution and only after consultation with a infectious disease specialist.
Primary options
ceftazidime: children: consult specialist for guidance on dose; adults: 1 g intravenously every 8-12 hours, maximum 6 g/day
Secondary options
cefepime: 1-2 g intravenously every 12 hours
OR
ticarcillin/clavulanic acid: children: consult specialist for guidance on dose; adults: 3.2 g intravenously every 6-8 hours, maximum 18-24 g/day
More ticarcillin/clavulanic acidDose consists of 3 g ticarcillin plus 0.2 g clavulanic acid.
OR
piperacillin: children: consult specialist for guidance on dose; adults: 3-4 g intravenously every 4-6 hours, maximum 24 g/day
OR
imipenem/cilastatin: 500-750 mg intravenously every 12 hours
More imipenem/cilastatinDose refers to imipenem component.
OR
aztreonam: 1-2 g intravenously every 8-12 hours
Tertiary options
amikacin: 7.5 mg/kg intravenously every 12 hours; or 5 mg/kg intravenously every 8 hours
OR
tobramycin: 3 mg/kg/day intravenously given in divided doses every 8 hours
hyperbaric oxygen
Additional treatment recommended for SOME patients in selected patient group
Hyperbaric oxygenation can be used in patients with refractory or recurrent disease, or in patients with extensive skull base or intracranial involvement although, in one systematic review, no clear evidence was found in demonstrating its efficacy when compared to treatment with antibiotics and/or surgery.[51]Sreepada GS, Kwartler JA. Skull base osteomyelitis secondary to malignant otitis externa. Curr Opin Otolaryngol Head Neck Surg. 2003 Oct;11(5):316-23. http://www.ncbi.nlm.nih.gov/pubmed/14502060?tool=bestpractice.com [53]Amaro CE, Espiney R, Radu L, et al. Malignant (necrotizing) externa otitis: the experience of a single hyperbaric centre. Eur Arch Otorhinolaryngol. 2019 Jul;276(7):1881-7. http://www.ncbi.nlm.nih.gov/pubmed/31165255?tool=bestpractice.com [54]Phillips JS, Jones SE. Hyperbaric oxygen as an adjuvant treatment for malignant otitis externa. Cochrane Database Syst Rev. 2013 May 31;(5):CD004617. http://onlinelibrary.wiley.com/doi/10.1002/14651858.CD004617.pub3/full http://www.ncbi.nlm.nih.gov/pubmed/23728650?tool=bestpractice.com
pain management
Additional treatment recommended for SOME patients in selected patient group
Analgesics increase patient satisfaction and allow faster return to normal activities.
Mild to moderate pain is usually controlled by paracetamol or a non-steroidal anti-inflammatory drug given alone or in combination with an opioid (e.g., paracetamol with codeine or paracetamol with oxycodone).[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com Analgesics should be started at the initial recommended dose and adjusted accordingly.
Codeine is contraindicated in children younger than 12 years, and it is not recommended in adolescents aged 12-18 years who are obese or have conditions such as obstructive sleep apnoea or severe lung disease as it may increase the risk of breathing problems.[61]US Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children aged 12 years and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[62]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON287006 [63]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144851.pdf
Primary options
paracetamol: children: 10-15 mg/kg orally/rectally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
paracetamol/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 15-60 mg orally orally every 4-6 hours
More paracetamol/codeineAdults: dose refers to codeine component. Maximum dose is based on paracetamol component of 4000 mg/day.
OR
oxycodone/paracetamol: adults: 5-10 mg orally (immediate-release) every 4-6 hours when required
More oxycodone/paracetamolAdults: dose refers to oxycodone component. Maximum dose is based on paracetamol component of 4000 mg/day.
fungal
topical or oral treatment
Frequent cleaning and debridement by medical professionals is necessary. Prior to the use of topical ear drops, the ear canal needs to be cleaned of any debris or wax by dry swabbing or microsuction.[18]Barry V, Bhamra N, Balai E, et al. Otitis externa. BMJ. 2021 Mar 31;372:n714. https://www.bmj.com/content/372/bmj.n714.long http://www.ncbi.nlm.nih.gov/pubmed/33789841?tool=bestpractice.com
Patients who have severe swelling of the ear canal may have difficulty in using ear drops. A wick should be inserted in the ear canal to allow for drug delivery.
The first line of treatment of fungal otitis externa is still in debate.[3]Hirsch BE. Infections of the external ear. Am J Otolaryngol. 1992 May-Jun;13(3):145-55. http://www.ncbi.nlm.nih.gov/pubmed/1626615?tool=bestpractice.com Acidifying agents such as acetic acid or aluminium acetate can be used.[12]Jackson EA, Geer K. Acute otitis externa: rapid evidence review. Am Fam Physician. 2023 Feb;107(2):145-51. http://www.ncbi.nlm.nih.gov/pubmed/36791445?tool=bestpractice.com [55]Hajioff D, Mackeith S. Otitis externa. BMJ Clin Evid. 2010 Aug 3;2010:0510. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3217807 http://www.ncbi.nlm.nih.gov/pubmed/21418684?tool=bestpractice.com Patients who do not respond to treatment with acidifying agents can be started on antifungal topical treatment.
Oral antifungals may be used if caused by candidal infection.[13]Selesnick SH. Otitis externa: management of the recalcitrant case. Am J Otology. 1994 May;15(3):408-12. http://www.ncbi.nlm.nih.gov/pubmed/8579150?tool=bestpractice.com [56]Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005 Nov;69(11):1503-8. http://www.ncbi.nlm.nih.gov/pubmed/15927274?tool=bestpractice.com Further studies are needed to assess the benefit of oral antifungal agents in otomycosis.[56]Martin TJ, Kerschner JE, Flanary VA. Fungal causes of otitis externa and tympanostomy tube otorrhea. Int J Pediatr Otorhinolaryngol. 2005 Nov;69(11):1503-8. http://www.ncbi.nlm.nih.gov/pubmed/15927274?tool=bestpractice.com Dose and duration of treatment for such an indication have not been fully studied. Itraconazole may be used if caused by Aspergillus infection.[16]Schaefer P, Baugh RF. Acute otitis externa: an update. Am Fam Physician. 2012 Dec 1;86(11):1055-61. https://www.aafp.org/afp/2012/1201/p1055.html http://www.ncbi.nlm.nih.gov/pubmed/23198673?tool=bestpractice.com
Topical antibiotic treatment, which is indicated in bacterial acute otitis externa, is contraindicated in fungal otitis externa because it is ineffective and may lead to further growth of fungi.[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com
In patients with tympanic membrane perforation, alcoholic solvents used to dissolve water-insoluble antifungal agents (e.g., clotrimazole) can also cause a burning or stinging sensation in the ear and may be ototoxic to the cochlea.[10]Koltsidopoulos P, Skoulakis C. Otomycosis with tympanic membrane perforation: a review of the literature. Ear Nose Throat J. 2020 Sep;99(8):518-21. https://journals.sagepub.com/doi/10.1177/0145561319851499?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed http://www.ncbi.nlm.nih.gov/pubmed/31142158?tool=bestpractice.com To overcome this, a wick saturated with the antifungal can be inserted in the ear canal to prevent the seepage of the irritant into the middle ear. Self-medication of clotrimazole solution with Q-tips has been shown to improve patient satisfaction and reduce recurrence.[58]Abou-Halawa AS, Khan MA, Alrobaee AA, et al. Otomycosis with perforated tympanic membrane: self medication with topical antifungal solution versus medicated ear wick. Int J Health Sci (Qassim). 2012 Jan;6(1):73-7. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3523785 http://www.ncbi.nlm.nih.gov/pubmed/23267306?tool=bestpractice.com
One study evaluating paper patches in tympanic membrane perforation found that closing the perforation with a patch and applying Castellani’s solution topically was safe and effective, and a faster resolution of otomycosis was observed, accompanied by reduced recurrence.[59]Görür K, İsmi O, Özcan C, et al. Treatment of otomycosis in ears with tympanic membrane perforation is easier with paper patch. Turk Arch Otorhinolaryngol. 2019 Dec;57(4):182-6. https://cms.galenos.com.tr/Uploads/Article_43067/tao-57-182-En.pdf http://www.ncbi.nlm.nih.gov/pubmed/32128515?tool=bestpractice.com
Primary options
acetic acid/hydrocortisone otic: (2%/1%) children ≥3 years of age and adults: 3-5 drops into the affected ear(s) three times daily for 7-10 days
OR
acetic acid otic: (2%) children and adults: 3-5 drops into the affected ear(s) three times daily for 7-10 days
OR
aluminium acetate topical: (8%) children and adults: consult product literature for guidance on dose
Secondary options
clotrimazole topical: (1%) children ≥2 years of age and adults: 3-4 drops into the affected ear(s) three to four times daily for 7-10 days
Tertiary options
fluconazole: children and adults: consult specialist for guidance on dose
OR
itraconazole: children and adults: consult specialist for guidance on dose
pain management
Additional treatment recommended for SOME patients in selected patient group
Analgesics increase patient satisfaction and allow faster return to normal activities.
Mild to moderate pain is usually controlled by paracetamol or a non-steroidal anti-inflammatory drug given alone or in combination with an opioid (e.g., paracetamol with codeine or paracetamol with oxycodone).[1]Rosenfeld RM, Schwartz SR, Cannon CR, et al. American Academy of Otolaryngology-Head and Neck Surgery Foundation. Clinical practice guideline: acute otitis externa. Otolaryngol Head Neck Surg. 2014 Feb;150(1 suppl):S1-24. [Erratum in: Otolaryngol Head Neck Surg. 2014 Mar;150(3):504]. https://aao-hnsfjournals.onlinelibrary.wiley.com/doi/10.1177/0194599813517083 http://www.ncbi.nlm.nih.gov/pubmed/24491310?tool=bestpractice.com Analgesics should be started at the initial recommended dose and adjusted accordingly.
Codeine is contraindicated in children younger than 12 years, and it is not recommended in adolescents aged 12-18 years who are obese or have conditions such as obstructive sleep apnoea or severe lung disease as it may increase the risk of breathing problems.[61]US Food and Drug Administration. FDA drug safety communication: FDA requires labeling changes for prescription opioid cough and cold medicines to limit their use to adults 18 years and older. January 2018 [internet publication]. https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-requires-labeling-changes-prescription-opioid-cough-and-cold It is generally recommended only for the treatment of acute moderate pain, which cannot be successfully managed with other analgesics, in children aged 12 years and older. It should be used at the lowest effective dose for the shortest period and treatment limited to 3 days.[62]Medicines and Healthcare products Regulatory Agency. Codeine: restricted use as analgesic in children and adolescents after European safety review. Drug Safety Update. December 2014 [internet publication]. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON287006 [63]European Medicines Agency. Restrictions on use of codeine for pain relief in children - CMDh endorses PRAC recommendation. June 2013 [internet publication]. http://www.ema.europa.eu/docs/en_GB/document_library/Press_release/2013/06/WC500144851.pdf
Primary options
paracetamol: children: 10-15 mg/kg orally/rectally every 4-6 hours when required, maximum 75 mg/kg/day; adults: 500-1000 mg orally every 4-6 hours when required, maximum 4000 mg/day
OR
ibuprofen: children: 5-10 mg/kg orally every 6-8 hours when required, maximum 40 mg/kg/day; adults: 200-400 mg orally every 4-6 hours when required, maximum 2400 mg/day
Secondary options
paracetamol/codeine: children ≥12 years of age: consult specialist for guidance on dose; adults: 15-60 mg orally orally every 4-6 hours
More paracetamol/codeineAdults: dose refers to codeine component. Maximum dose is based on paracetamol component of 4000 mg/day.
OR
oxycodone/paracetamol: adults: 5-10 mg orally (immediate-release) every 4-6 hours when required
More oxycodone/paracetamolAdults: dose refers to oxycodone component. Maximum dose is based on paracetamol component of 4000 mg/day.
tympanoplasty or myringoplasty
Typically, tympanic membrane perforation due to fungal otitis externa is smaller in size and may resolve with treatment. However, some cases may require tympanoplasty or myringoplasty to close the perforation.[10]Koltsidopoulos P, Skoulakis C. Otomycosis with tympanic membrane perforation: a review of the literature. Ear Nose Throat J. 2020 Sep;99(8):518-21. https://journals.sagepub.com/doi/10.1177/0145561319851499?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%20%200pubmed http://www.ncbi.nlm.nih.gov/pubmed/31142158?tool=bestpractice.com
Choose a patient group to see our recommendations
Please note that formulations/routes and doses may differ between drug names and brands, drug formularies, or locations. Treatment recommendations are specific to patient groups. See disclaimer
Use of this content is subject to our disclaimer